ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q: What does CUSIP 00166B105 represent in this 13F holders report?

CUSIP 00166B105 is the security identifier for ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in Q2 2022?

92 institutional investors reported ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 00166B105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 132,570,600
Total 13F shares: 35,930,829
Share change: -838,662
Total reported value: $290,675,201
Put/Call ratio: 0.74%
Price per share: $8.09
Number of holders: 92
Value change: -$16,579,357
Number of buys: 52
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 00166B105?
CUSIP 00166B105 identifies ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 00166B105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
venBio Partners LLC	13F	Company	7.3%	9,699,925	$163,929,000	—	31 Mar 2022	13F
Vivo Capital, LLC	13F	Company	3.2%	4,220,048	$71,319,000	—	31 Mar 2022	13F
LSV Associates, LLC	3/4/5	10%+ Owner	— class O/S missing	4,526,963	$61,575,751	—	13 Dec 2021	3/4/5
FMR LLC	13F	Company	2.7%	3,558,954	$60,147,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	2.3%	3,011,352	$50,892,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	2,809,826	$47,486,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.6%	2,133,744	$36,060,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1.3%	1,675,656	$28,318,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1%	1,355,478	$22,907,000	—	31 Mar 2022	13F
Redmile Group, LLC	13F	Company	0.58%	772,397	$13,054,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	0.54%	712,079	$12,034,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.49%	643,487	$10,875,000	—	31 Mar 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.47%	621,700	$10,507,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	0.38%	500,000	$8,450,000	—	31 Mar 2022	13F
Pier Capital, LLC	13F	Company	0.3%	394,443	$6,666,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.29%	384,515	$6,497,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.28%	365,653	$6,179,535	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.26%	343,663	$5,807,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	320,341	$5,413,000	—	31 Mar 2022	13F
Samsara BioCapital, LLC	13F	Company	0.2%	262,786	$4,441,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.16%	214,486	$3,625,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.16%	212,837	$3,597,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.13%	173,677	$2,935,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.12%	156,876	$2,651,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.11%	148,800	$2,515,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	147,095	$2,486,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	134,030	$2,265,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	133,479	$2,256,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.1%	127,432	$2,154,000	—	31 Mar 2022	13F
AXA S.A.	13F	Company	0.09%	124,199	$2,098,963	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	112,800	$1,906,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.06%	86,072	$1,455,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.06%	74,083	$1,252,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.05%	66,211	$1,119,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.05%	61,000	$1,030,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	58,681	$992,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	55,412	$936,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.04%	54,107	$914,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	48,626	$872,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	51,200	$865,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.04%	50,694	$857,000	—	31 Mar 2022	13F
Vident Investment Advisory, LLC	13F	Company	0.04%	50,123	$847,000	—	31 Mar 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.03%	43,548	$736,000	—	31 Mar 2022	13F
Nan Fung Group Holdings Ltd	13F	Company	0.03%	41,950	$709,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.03%	41,764	$706,000	—	31 Mar 2022	13F
Jump Financial, LLC	13F	Company	0.03%	39,300	$664,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.03%	35,126	$594,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	34,032	$575,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	32,900	$556,000	—	31 Mar 2022	13F
Financial Advisory Group	13F	Company	0.02%	31,417	$531,000	—	31 Mar 2022	13F

Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q2 2022

As of 30 Jun 2022, ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,930,829 shares. The largest 10 holders included venBio Partners LLC, Vivo Capital, LLC, FMR LLC, Logos Global Management LP, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, and Cormorant Asset Management, LP. This page lists 92 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-2

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.